The abstract is read at the publisher; the summary is JClub's.
An NFAT-inducible lentiviral CRISPR-Cas9 system targeting HIV-1 gag, tat/rev, and CCR5 disrupts viral genome and replication in latently infected cell models.
- Why it matters: HIV-1 persists as an integrated latent provirus that can reactivate if therapy is stopped, and continuous nuclease activity raises off-target and safety concerns.
- What they did: A lentiviral vector was built to express Cas9 under an NFAT-inducible promoter, paired with guide RNAs against HIV-1 gag and tat/rev and the host entry factor CCR5, then tested across cellular models for activation-dependent editing and viral disruption.
- The result: Inducible Cas9 expression upon cellular activation was linked to functional inactivation of HIV-1 in vitro, supporting a conditional gene-editing strategy to reduce drawbacks of continuous nuclease activity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.